All currently US Food and Drug Administration (FDA)-approved insulin still have a narrow therapeutic window: insulin overdoses lead to hypoglycemia and underdoses result in hyperglycemia (Peyrot et al., 2012). The gene discussed is INS; the disease is Hypoglycemia.